CODY HUDSON: Open Payments
NPI 1518722743 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 66 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $802 · 2025 $1,116
Food & beverage: $1,116
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $275 |
| Novartis Pharmaceuticals Corporation | 16 | $176 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $151 |
| Amgen Inc. | 9 | $141 |
| Novo Nordisk Inc | 4 | $62 |
| Medtronic, Inc. | 2 | $52 |
| Boston Scientific Corporation | 2 | $52 |
| PFIZER INC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| Biosense Webster, Inc. | 1 | $34 |
Products named: LOKELMA, LifeVest, LEQVIO, REPATHA, FARXIGA, COREVALVE EVOLUT R, ELIQUIS, Wegovy.
Industry payments across MO — which companies pay providers there.
